Physician profile
Michael J Chillo
NPI 1841549581
$1,250.01
in general payments reported to CMS, 2019-2025
10 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $258 · 2023: $292 · 2024: $397 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $991.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $239.00 | 2024 | Mitraclip |
| Medtronic, INC. | $169.65 | 2025 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $155.30 | 2023 | Sapien 3 Ultra Resilia |
| Chiesi USA, INC. | $136.37 | 2023 | Cleviprex |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2024 | Camzyos |
| Convatec INC. | $124.99 | 2021 | |
| Baxter Healthcare | $119.06 | 2021 | |
| Atricure, INC. | $99.95 | 2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Merck Sharp & Dohme LLC | $66.41 | 2024-2025 | Keytruda |
| Janssen Pharmaceuticals, INC | $14.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Chillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.